Wait, What? Fibrosis Is a Repair Programme That Forgot to Stop
Collagen is not bad.
Fibroblasts are not bad.
Scar formation can save tissue after injury.
The problem arises when repair signalling persists.
injury → inflammation → fibroblast activation → matrix deposition → repair
can become:
persistent injury → persistent myofibroblasts → excessive matrix → stiffness → further signalling → fibrosis
Fibrosis is not simply “too much collagen”.
It is a self-reinforcing tissue state.
The One-Sentence Answer
Learn fibrosis by first understanding normal repair, then identify what prevents myofibroblasts and extracellular-matrix production from switching off after the original injury has passed.
Stage 1: Normal Repair Needs Temporary Matrix
After injury, provisional matrix:
- stabilises tissue;
- gives cells a scaffold;
- supports revascularisation.
Later, the matrix should be remodelled.
Stage 2: Fibroblasts Are Major Matrix-Producing Cells
Fibroblasts produce:
- collagen;
- fibronectin;
- proteoglycans;
- matrix-regulating enzymes.
Different organs contain distinct fibroblast populations.
Stage 3: Myofibroblasts Are Activated Contractile States
Myofibroblasts express contractile machinery such as α-smooth-muscle-actin-related systems and produce abundant matrix.
They help close wounds.
They become problematic when they persist.
Stage 4: TGF-β Is a Major Profibrotic Signal
TGF-β can drive:
- fibroblast activation;
- collagen production;
- reduced matrix degradation.
But no single cytokine explains every fibrotic disease.
Stage 5: Immune Cells Shape Fibrosis
Macrophages and other immune cells can provide:
- TGF-β;
- growth factors;
- inflammatory signals.
Different immune states can promote injury, repair or resolution.
Stage 6: Matrix Stiffness Becomes a Signal
As collagen accumulates and cross-links, tissue stiffens.
Cells sense that stiffness through:
- integrins;
- cytoskeleton;
- YAP/TAZ-related pathways.
The matrix stops being only an output.
It becomes an input.
Stage 7: This Creates Positive Feedback
Stiffer matrix can promote further myofibroblast activation.
More myofibroblasts produce more matrix.
This is one mechanism by which fibrosis becomes self-sustaining.
Stage 8: Collagen Cross-Linking Stabilises Scar
Lysyl oxidase-related enzymes strengthen collagen networks.
Cross-linked matrix becomes harder to remodel.
Mechanical persistence increases.
Stage 9: MMPs and TIMPs Regulate Matrix Turnover
Matrix metalloproteinases degrade selected matrix components.
TIMPs inhibit those enzymes.
Fibrosis depends on both synthesis and degradation.
High collagen can result from:
- more production;
- less removal;
- both.
Stage 10: Fibrosis Is Organ-Specific
In liver, hepatic stellate cells are major fibrogenic players.
In lung, several fibroblast populations participate.
In kidney and heart, perivascular and interstitial cells contribute differently.
There is no one universal fibroblast.
Stage 11: Liver Fibrosis Can Regress
Remove the chronic injury in some contexts and:
- activated stellate cells can die or deactivate;
- matrix can remodel;
- architecture can partially recover.
Fibrosis is not always irreversible.
Stage 12: Advanced Scarring Is Harder to Reverse
Long-standing cross-linked matrix, vascular distortion and tissue loss reduce reversibility.
Timing matters.
Stage 13: Lung Fibrosis Changes Gas-Exchange Architecture
Excess matrix thickens and remodels tissue.
The injury is not simply “collagen in the lung”.
It changes the geometry needed for effective gas exchange.
Stage 14: Cardiac Fibrosis Alters Electrical and Mechanical Function
Scar can:
- stiffen myocardium;
- disrupt conduction;
- alter force transmission.
Same collagen. Different receiver.
Stage 15: Kidney Fibrosis Compresses Functional Microarchitecture
Tubules and capillaries become distorted.
Fibrosis therefore reduces function by changing tissue organisation, not only by occupying volume.
Stage 16: Fibrosis and Senescence Interact
Senescent cells can release profibrotic SASP factors.
Fibrotic environments can create stress that encourages further senescence.
The two processes can reinforce one another.
Stage 17: Hypoxia Can Amplify Fibrogenic Signalling
Damaged microvasculature can reduce oxygen delivery.
Hypoxia-inducible pathways can alter fibroblast and epithelial behaviour.
Stage 18: Epithelial Injury Is Often Upstream
In lung, kidney and liver, repeated epithelial or parenchymal injury can continually restart repair.
Fibroblasts may be the matrix producers without being the original cause.
Stage 19: Measuring Fibrosis Requires More Than Looking at Collagen
Methods include:
- histology;
- hydroxyproline;
- elastography;
- MRI;
- serum biomarkers;
- spatial omics.
Each sees a different layer.
Stage 20: Histology Gives Spatial Structure
Stains such as Masson’s trichrome or Sirius red can reveal collagen-rich regions.
Quantification must account for sampling and tissue orientation.
Stage 21: Hydroxyproline Estimates Collagen Content
Hydroxyproline is abundant in collagen.
Biochemical assays can estimate total collagen.
But they lose spatial information.
Stage 22: Elastography Measures Stiffness, Not Fibrosis Directly
Ultrasound or MR elastography estimates tissue mechanical properties.
Stiffness can rise with fibrosis.
It can also change with:
- inflammation;
- congestion;
- pressure.
Measured property ≠ unique mechanism.
Stage 23: Single-Cell Atlases Reveal Fibroblast States
Modern sequencing shows multiple fibroblast and myofibroblast populations within the same organ.
Fibrosis is a changing ecosystem.
Stage 24: Spatial Transcriptomics Adds Neighbourhood
Where a fibroblast sits relative to:
- injured epithelium;
- macrophages;
- vessels
can explain its activation programme.
Stage 25: Anti-Fibrotic Treatment Is a Multi-Target Problem
Potential targets include:
- injury source;
- inflammation;
- TGF-β pathways;
- mechanotransduction;
- matrix cross-linking;
- myofibroblast survival.
Blocking all repair would be dangerous.
The aim is not “zero collagen”.
Stage 26: Professional Fibrosis Science Is a Persistence Problem
The key question becomes:
Which injury signal, fibroblast state, immune interaction or mechanical-feedback loop prevents normal wound repair from resolving in this organ?
Misconceptions Worth Hunting
- Collagen is inherently harmful.
- Fibrosis is just extra collagen.
- Fibroblasts are the original cause of every fibrotic disease.
- TGF-β explains all fibrosis.
- Stiffness proves fibrosis uniquely.
- Fibrosis is always irreversible.
- All organs use the same fibroblast programme.
- Eliminating all fibroblasts would be therapeutic.
Transfer Check
A wound forms a temporary scar and then remodels.
Is that fibrosis?
Not necessarily.
Now persistent injury keeps myofibroblasts active.
What changed?
The repair programme failed to resolve.
Finally, elastography shows increased stiffness.
Does that alone prove collagen accumulation?
No.
Model Limits
Animal fibrosis models often use acute injury while human disease may develop over years. Fibroblast markers overlap across states. Stiffness measurements are indirect. Spatial sampling can miss heterogeneous lesions.
Professional fibrosis science keeps:
injury source + fibroblast state + matrix turnover + immune signalling + mechanics + resolution
visible together.
The Quiet Ending
The beginner asks, “Why is scar tissue building up?”
The developing biologist asks, “Which repair signal failed to switch off?”
And the professional asks:
Which cellular, immune and mechanical feedback loop is preventing this tissue from returning from repair mode to normal function?
eduKate Sengkang 